Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Issa AM, Thorogood A, Joly Y, Knoppers BM, “Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations” (2019) 21:3 Genetics in Medicine, 542-544.

This content has been updated on October, 1 2019 at 11 h 55 min.